GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exicure Inc (STU:2H0A) » Definitions » Research & Development

Exicure (STU:2H0A) Research & Development : €1.33 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Exicure Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Exicure's Research & Development for the three months ended in Dec. 2023 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was €1.33 Mil.

Exicure Research & Development Historical Data

The historical data trend for Exicure's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exicure Research & Development Chart

Exicure Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial 17.41 26.38 43.35 18.66 1.31

Exicure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.01 1.33 - - -

Exicure Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exicure  (STU:2H0A) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Exicure Research & Development Related Terms

Thank you for viewing the detailed overview of Exicure's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Exicure (STU:2H0A) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exicure Inc (STU:2H0A) » Definitions » Research & Development
Comparable Companies
WINT FRTX CVKD ALRN IMPL LIXT RGBP PKTX PALI NAVB OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
XCUR:USA
Address
2430 N. Halsted Street, Suite 410, Chicago, IL, USA, 60614
Website
https://www.exicuretx.com
Exicure Inc is a biotechnology company that develops nucleic acid therapies targeting ribonucleic acid against validated targets for neurological disorders and hair loss. It operates in a single segment, which is the discovery, research, and development of treatments based on its SNA (Spherical Nucleic Acid) technology.

Exicure (STU:2H0A) Headlines

No Headlines